M. Isabel Pérez-Morgado

Author

Hospital Universitario Ramón y Cajal ORCID

Also Known As

M Isabel Pérez-Morgado, M. Isabel Pérez-Morgado, M.I Pérez-Morgado, M.I. Pérez-Morgado, M.Isabel Pérez-Morgado, María Isabel Pérez-Morgado

Publications

318

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Ramón y Cajal Instituto Ramón y Cajal de Investigación Sanitaria Universidad de Alcalá

About

M. Isabel Pérez-Morgado is an author at Hospital Universitario Ramón y Cajal specializing in cell biology, medicine, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	216
2	Cell Biology	6	6	216
3	Natural Sciences	2	2	94
4	Biochemistry	2	2	94
5	Cellular Physiology	1	1	11

M. Isabel Pérez-Morgado

Publications

295

Citations

H-Index

Page 1

	Year	Citations
Identification and molecular characterization of Mnk1b, a splice variant of human MAP kinase-interacting kinase Mnk1 Ana O’Loghlen, Vı́ctor M. González, David Piñeiro, Experimental Cell Research Molecular CharacterizationSignal TransductionSignaling PathwayGeneticsSplice Variant	2004	65
Reversible inhibition of the protein phosphatase 1 by hydrogen peroxide. Potential regulation of eIF2α phosphorylation in differentiated PC12 cells Ana O’Loghlen, M. Isabel Pérez-Morgado, María Salinas, Archives of Biochemistry and Biophysics Protein Phosphatase 1Redox SignalingSignal TransductionBiochemistryReversible Inhibition	2003	51
N-acetyl-cysteine abolishes hydrogen peroxide-induced modification of eukaryotic initiation factor 4F activity via distinct signalling pathways Ana O’Loghlen, M. Isabel Pérez-Morgado, María Salinas Cellular Signalling Reductive StressBiochemistryReactive Nitrogen SpecieNatural SciencesLipid Peroxidation	2005	43
Characterization of MNK1b DNA Aptamers That Inhibit Proliferation in MDA-MB231 Breast Cancer Cells Eva M. García-Recio, Celia Pinto‐Díez, M. Isabel Pérez-Morgado, Molecular Therapy — Nucleic Acids	2016	39
Eukaryotic Initiation Factors (eIF) 2α and 4E Expression, Localization, and Phosphorylation in Brain Tumors Sonia Tejada, María V.T. Lobo, Mercedes García-Villanueva, Journal of Histochemistry & Cytochemistry Neuro-oncologyTranscriptional RegulationRadiation OncologyTumor InnervationGlioma	2009	36
Increased expression of MNK1b, the spliced isoform of MNK1, predicts poor prognosis and is associated with triple-negative breast cancer Celia Pinto‐Díez, Eva M. García-Recio, M. Isabel Pérez-Morgado, Oncotarget	2018	16
An optimized MNK1b aptamer, apMNKQ2, and its potential use as a therapeutic agent in breast cancer Celia Pinto‐Díez, Raquel Ferreras-Martín, Rebeca Carrión-Marchante, Molecular Therapy — Nucleic Acids	2022	13
eIF4F complex disruption causes protein synthesis inhibition during hypoxia in nerve growth factor (NGF)-differentiated PC12 cells Macarena Hernández‐Jiménez, María Irene Ayuso, M. Isabel Pérez-Morgado, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research Developmental BiologySignal TransductionSignaling PathwayCell RegulationMedicine	2011	11
Potential Therapeutic Use of Aptamers against HAT1 in Lung Cancer José Ignacio Klett-Mingo, Celia Pinto‐Díez, Julio Cambronero-Plaza, Cancers	2022	11
DNA Aptamers against Vaccinia-Related Kinase (VRK) 1 Block Proliferation in MCF7 Breast Cancer Cells Rebeca Carrión-Marchante, Valerio Frezza, Ana Salgado-Figueroa, Pharmaceuticals Breast OncologyCancer-associated VirusReceptor Tyrosine KinaseImmunologyDna Aptamers	2021	10

Page 1